Looking at how well drugs work in routine clinical practice, rather than only in experimental randomised controlled clinical trials (RCTs), is increasingly seen as essential for a proper assessment of both net benefit (health gain minus harm and value (net benefit minus net cost). Establishing...

Triggered by the COVID-19 crisis, Israel's Ministry of Health (MoH) held a virtual datathon based on deidentified governmental data. Organized by a multidisciplinary committee, Israel's research community was invited to offer insights to help solve COVID-19 policy challenges. The Datathon was...

In this paper, we discuss 10 parallels between the lack of preparation of financial system regulators prior to the GFC and the lack of preparation by public health authorities and governments prior to Covid-19. These parallels relate to: required stocks (of capital or equipment), data collection...